199 related articles for article (PubMed ID: 12050374)
1. Characterization of producer cell-dependent restriction of murine leukemia virus replication.
Serhan F; Jourdan N; Saleun S; Moullier P; Duisit G
J Virol; 2002 Jul; 76(13):6609-17. PubMed ID: 12050374
[TBL] [Abstract][Full Text] [Related]
2. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
Song YE; Olinger GY; Janaka SK; Johnson MC
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
[TBL] [Abstract][Full Text] [Related]
3. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
4. Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.
Gregory DA; Lyddon TD; Johnson MC
J Virol; 2013 Feb; 87(3):1518-27. PubMed ID: 23152533
[TBL] [Abstract][Full Text] [Related]
5. Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu.
Lucas TM; Lyddon TD; Cannon PM; Johnson MC
J Virol; 2010 Mar; 84(6):2666-74. PubMed ID: 20042505
[TBL] [Abstract][Full Text] [Related]
6. Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection.
Walker SJ; Pizzato M; Takeuchi Y; Devereux S
J Virol; 2002 Jul; 76(14):6909-18. PubMed ID: 12072492
[TBL] [Abstract][Full Text] [Related]
7. Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein.
Sandrin V; Cosset FL
J Biol Chem; 2006 Jan; 281(1):528-42. PubMed ID: 16195228
[TBL] [Abstract][Full Text] [Related]
8. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira NM; Trikha R; McKnight Á
Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
[TBL] [Abstract][Full Text] [Related]
9. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA
mBio; 2020 Jan; 11(1):. PubMed ID: 31964738
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of infectious murine leukemia virus production by Fv-4 env gene products exerting dominant negative effect on viral envelope glycoprotein.
Takeda A; Matano T
Microbes Infect; 2007; 9(14-15):1590-6. PubMed ID: 18023391
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
12. Replacement of the murine leukemia virus (MLV) envelope gene with a truncated HIV envelope gene in MLV generates a virus with impaired replication capacity.
Nack U; Schnierle BS
Virology; 2003 Oct; 315(1):209-16. PubMed ID: 14592772
[TBL] [Abstract][Full Text] [Related]
13. Construction of a replication-competent retroviral vector for expression of the VSV-G envelope glycoprotein for cancer gene therapy.
Jin SY; Jung YT
Arch Virol; 2020 May; 165(5):1089-1097. PubMed ID: 32146506
[TBL] [Abstract][Full Text] [Related]
14. Construction of replication-competent oncolytic retroviral vectors expressing R peptide-truncated 10A1 envelope glycoprotein.
Lee ES; Jin SY; Kang BK; Jung YT
J Virol Methods; 2019 Jun; 268():32-36. PubMed ID: 30898575
[TBL] [Abstract][Full Text] [Related]
15. Differences in the internalization of self-inactivating VSVG-pseudotyped murine leukemia virus-based vectors in human and murine cells.
Acevedo ML; García-de Gracia F; Miranda-Cárdenas C; Soto-Rifo R; Aguayo F; León O
J Virol Methods; 2018 May; 255():14-22. PubMed ID: 29425681
[TBL] [Abstract][Full Text] [Related]
16. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.
Giroglou T; Cinatl J; Rabenau H; Drosten C; Schwalbe H; Doerr HW; von Laer D
J Virol; 2004 Sep; 78(17):9007-15. PubMed ID: 15308697
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of Fv1: effects on retroviral restriction specificities.
Li W; Yap MW; Voss V; Stoye JP
Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
[TBL] [Abstract][Full Text] [Related]
18. O-sulfate groups of heparin are critical for inhibition of ecotropic murine leukemia virus infection by heparin.
Seki Y; Mizukura M; Ichimiya T; Suda Y; Nishihara S; Masuda M; Takase-Yoden S
Virology; 2012 Mar; 424(1):56-66. PubMed ID: 22226323
[TBL] [Abstract][Full Text] [Related]
19. Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity.
Diehl WE; Guney MH; Vanzo T; Kyawe PP; White JM; Pizzato M; Luban J
Viruses; 2021 Jun; 13(7):. PubMed ID: 34209034
[TBL] [Abstract][Full Text] [Related]
20. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction.
Pizzato M; Marlow SA; Blair ED; Takeuchi Y
J Virol; 1999 Oct; 73(10):8599-611. PubMed ID: 10482613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
